213 related articles for article (PubMed ID: 19758789)
1. HTR2A gene variation is involved in antidepressant treatment response.
Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
[TBL] [Abstract][Full Text] [Related]
2. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
[TBL] [Abstract][Full Text] [Related]
3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
4. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
[TBL] [Abstract][Full Text] [Related]
6. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 34 candidate genes in bupropion and placebo remission.
Tiwari AK; Zai CC; Sajeev G; Arenovich T; Müller DJ; Kennedy JL
Int J Neuropsychopharmacol; 2013 May; 16(4):771-81. PubMed ID: 22947179
[TBL] [Abstract][Full Text] [Related]
8. Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the
Gassó P; Blázquez A; Rodríguez N; Boloc D; Torres T; Mas S; Lafuente A; Lázaro L
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):711-718. PubMed ID: 29975559
[No Abstract] [Full Text] [Related]
9. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
10. Somatization in major depression--clinical features and genetic associations.
Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
[TBL] [Abstract][Full Text] [Related]
11. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Tsunoka T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
Neurosci Res; 2009 Jun; 64(2):231-4. PubMed ID: 19428704
[TBL] [Abstract][Full Text] [Related]
12. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
13. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Int Clin Psychopharmacol; 2016 Jan; 31(1):1-7. PubMed ID: 26544898
[TBL] [Abstract][Full Text] [Related]
14. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies of drug response and side effects in the STAR*D study, part 2.
Garriock HA; Hamilton SP
J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
[No Abstract] [Full Text] [Related]
16. Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.
Houston JP; Kohler J; Ostbye KM; Heinloth A; Perlis RH
Psychiatry Res; 2011 Oct; 189(3):475-7. PubMed ID: 21788083
[TBL] [Abstract][Full Text] [Related]
17. Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis.
Lin JY; Jiang MY; Kan ZM; Chu Y
J Affect Disord; 2014 Oct; 168():430-8. PubMed ID: 25108775
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
[TBL] [Abstract][Full Text] [Related]
19. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
[TBL] [Abstract][Full Text] [Related]
20. A genomewide association study of citalopram response in major depressive disorder.
Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
